are the indian products the same compounds or something else entirely
#asia 2026-02-24
Tuesday39 messages9 participantstimes are UTC
Highlights from this day
- taipei_tare — insurance in the region tracked the diabetes indication in every country a member reported on 22:24
- vacuum_vic — japan approved it a while back didnt it, what does it cost there 22:26
- manila_meniscus — right so how careful should i be about the claims on an indian generic 22:53
- VialBot — Verification log updated: Homopeptide — evidence added, status unchanged. 23:11
- rotterdam_recon — whats the position in taiwan or thailand, anyone at all 23:34
transit inside the region ran 25 days for me, which was not faster than a longer route with a better carrier
a member in tokyo reported an out of pocket cost in the region of twenty thousand yen a month in 2024, at a clinic
📈2📉7
nobody here can tell you what will clear customs where you are and that is enforced in this channel
insurance in the region tracked the diabetes indication in every country a member reported on
[edited]👀15🎉8
japan approved it a while back didnt it, what does it cost there
💀14😂1🙏1
hong kong members reported both clinic and pharmacy routes and a wide price range between the two
singapore was reported in here at around 400 to 600 singapore dollars a month a year or so ago, prescription only
as of about a year ago korea had the shortest path from deciding to starting of anywhere members here had described
language with a local pharmacy went better once i brought the compound name written down. spoken, it never worked once
a korean member said their clinic visit took under an hour end to end, which is not a claim about the quality of the assessment
*Medutest not the other one
what does a month come to in singapore dollars
japan approved it for both indications a while ago as i understood it, and the approval did not make it cheap
every price in this channel is a snapshot from the month it was typed. pricing in the region moved a lot and unevenly, happy to be corrected
write it down for the pharmacy
the carrier matters
is it easier to get seen about this in korea than in europe
update on the earlier thing closer supplier, fewer flight hours, same number of customs steps. the steps are the slow part
right so how careful should i be about the claims on an indian generic
💀13🤝1📉1
get it tested anyway
how do people handle the language side with a local pharmacy
diabetes indication only
🧪7❤️1📈5
anyone had a parcel stopped moving between two asian countries
approval isnt cheap
while im here japanese insurance covered the diabetes indication and not the weight one as far as anyone here could establish a year ago, happy to be corrected
customs between asian countries has not been noticeably easier in anything members have reported. each border is its own border
same customs steps
korea and the clinic culture, is it as easy to get as people say
Verification log updated: Homopeptide — evidence added, status unchanged.
japan being expensive despite the approval is the pattern. approval sets the licence and the pricing system sets the price
coming back after 23 months, has anything changed on availability in the region
figures are from last year
is it covered by insurance anywhere in the region
the indian landscape is qualitatively different from research supply, it is a licensed pharmaceutical industry, and that is still not a guarantee about the vial you received
whats the position in taiwan or thailand, anyone at all
🎉2❤️16🧊6
forty percent apart
held for 12 days
✅12👍1🎉4
singapore handles personal quantities of prescription medicine under its own rules and i would not try to summarise them from memory
avoid august